Life Sciences Solutions — Segment assets

Business Segments · Segment assets

Thermo Fisher Scientific Life Sciences Solutions — Segment assets decreased by 3.0% to $3.45B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 15.6%, from $2.98B to $3.45B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
Rolls up toTotal Assets

How to read this metric

An increase suggests capital expansion or investment in segment-specific infrastructure, while a decrease may indicate asset divestiture or improved capital efficiency.

Detailed definition

This metric represents the total book value of assets specifically allocated to the Life Sciences Solutions operating se...

Peer comparison

Comparable to segment-specific asset bases reported by diversified life science and biotechnology tool providers.

Metric ID: tmo_segment_life_sciences_solutions_segment_assets

Historical Data

5 periods
 Q4 '23Q3 '24Q4 '24Q3 '25Q4 '25
Value$3.19B$3.21B$2.98B$3.55B$3.45B
QoQ Change+0.8%-7.1%+19.1%-3.0%
YoY Change-6.4%+10.6%+15.6%
Range$2.98B$3.55B
CAGR+8.2%
Avg YoY Growth+6.6%
Median YoY Growth+10.6%

Frequently Asked Questions

What is Thermo Fisher Scientific's life sciences solutions — segment assets?
Thermo Fisher Scientific (TMO) reported life sciences solutions — segment assets of $3.45B in Q4 2025.
How has Thermo Fisher Scientific's life sciences solutions — segment assets changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — segment assets increased by 15.6% year-over-year, from $2.98B to $3.45B.
What does life sciences solutions — segment assets mean?
The total value of all assets dedicated to the Life Sciences Solutions business segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.